Unichem Laboratories Ltd.

NSE: UNICHEMLAB | BSE: 506690 | ISIN: INE351A01035 | Industry: Pharmaceuticals
| Mid-range Performer
490.8500 -3.85 (-0.78%)
NSE Sep 24, 2025 15:49 PM
Volume: 6,699
 

490.85
-0.78%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research In an important development that will have implications on the future of the company, the Unichem management has decided to offer its core domestic branded formulations business to Torrent Pharma. The deal is valued at | 3600 crore (~4.3x FY17 Unichem's domestic revenue). The binding agreement includes 3000 Unichem employees and its Sikkim plant. Domestic revenues contributed ~54% to Unichem's FY17 revenues and included key brands like Losar, Unienzyme, Ampoxin, Telsar and...
Unichem Laboratories Ltd. has lost -30.84% in the last 6 Months
More from Unichem Laboratories Ltd.
Recommended